JANICE HILLEY: Open Payments
NPI 1003232430 · SEAFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 27 payments from 26 companies in 2025. Trend: 2023 $339 · 2024 $511 · 2025 $713
Food & beverage: $614Education: $99
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| ABBVIE INC. | 1 | $34 |
| Genmab U.S., Inc. | 1 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Celgene Corporation | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| PharmaEssentia USA Corporation | 1 | $28 |
| BeOne Medicines USA, Inc. | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $26 |
Products named: Fabhalta, ELAHERE, Epkinly, Onivyde, REBLOZYL, Nubeqa, BESREMI, TEVIMBRA.
Industry payments across DE — which companies pay providers there.
